Struma ovarii screening: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
*There is insufficient evidence to recommend routine screening for Struma ovarii. | *There is insufficient evidence to recommend routine screening for Struma ovarii. | ||
* | *For follow-up as a marker of recurrence, serum thyroglobulin levels and I131 scan may be used. <ref name="pmid12821363">{{cite journal |vauthors=Volpi E, Ferrero A, Nasi PG, Sismondi P |title=Malignant struma ovarii: a case report of laparoscopic management |journal=Gynecol. Oncol. |volume=90 |issue=1 |pages=191–4 |year=2003 |pmid=12821363 |doi= |url=}}</ref> <ref name="pmid17168212">{{cite journal |vauthors=Zekri JM, Manifold IH, Wadsley JC |title=Metastatic struma ovarii: late presentation, unusual features and multiple radioactive iodine treatments |journal=Clin Oncol (R Coll Radiol) |volume=18 |issue=10 |pages=768–72 |year=2006 |pmid=17168212 |doi= |url=}}</ref> | ||
*The I131 scan or thyroglobulin have no aid in the follow-up if thyroidectomy is not performed. <ref name="pmid15963556">{{cite journal |vauthors=Balci TA, Kabasakal L |title=Is the I-131 whole-body scanning proper for follow-up management of the patients with malignant struma ovarii without performing the thyroidectomy? |journal=Gynecol. Oncol. |volume=99 |issue=2 |pages=520 |year=2005 |pmid=15963556 |doi=10.1016/j.ygyno.2005.04.017 |url=}}</ref> | |||
*In cases of metastatic struma ovarii post total thyroidectomy along with radioiodine scanning and radioiodine ablation, the thyroglobulin levels must be monitored as a tumor marker, and diagnostic radioiodine scans should be done to screen for residual or recurrent disease. <ref name="pmid19289330">{{cite journal| author=McGill JF, Sturgeon C, Angelos P| title=Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation. | journal=Endocr Pract | year= 2009 | volume= 15 | issue= 2 | pages= 167-73 | pmid=19289330 | doi=10.4158/EP.15.2.167 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19289330 }} </ref> | |||
==References== | ==References== | ||
Revision as of 19:33, 20 August 2017
|
Struma ovarii Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Struma ovarii screening On the Web |
|
American Roentgen Ray Society Images of Struma ovarii screening |
|
Risk calculators and risk factors for Struma ovarii screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for Struma ovarii.
Screening
- There is insufficient evidence to recommend routine screening for Struma ovarii.
- For follow-up as a marker of recurrence, serum thyroglobulin levels and I131 scan may be used. [1] [2]
- The I131 scan or thyroglobulin have no aid in the follow-up if thyroidectomy is not performed. [3]
- In cases of metastatic struma ovarii post total thyroidectomy along with radioiodine scanning and radioiodine ablation, the thyroglobulin levels must be monitored as a tumor marker, and diagnostic radioiodine scans should be done to screen for residual or recurrent disease. [4]
References
- ↑ Volpi E, Ferrero A, Nasi PG, Sismondi P (2003). "Malignant struma ovarii: a case report of laparoscopic management". Gynecol. Oncol. 90 (1): 191–4. PMID 12821363.
- ↑ Zekri JM, Manifold IH, Wadsley JC (2006). "Metastatic struma ovarii: late presentation, unusual features and multiple radioactive iodine treatments". Clin Oncol (R Coll Radiol). 18 (10): 768–72. PMID 17168212.
- ↑ Balci TA, Kabasakal L (2005). "Is the I-131 whole-body scanning proper for follow-up management of the patients with malignant struma ovarii without performing the thyroidectomy?". Gynecol. Oncol. 99 (2): 520. doi:10.1016/j.ygyno.2005.04.017. PMID 15963556.
- ↑ McGill JF, Sturgeon C, Angelos P (2009). "Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation". Endocr Pract. 15 (2): 167–73. doi:10.4158/EP.15.2.167. PMID 19289330.